VCM
UPB

Versant Capital Management’s Upstream Bio Inc UPB Stock Holding History

Versant Capital Management’s Portfolio UPB Stock Details UPB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-762
Closed -$6.86K – 2867
2026
Q1 		$6.86K Buy
762
+204
+37% +$3.67K ﹤0.01% 2289
2025
Q4 		$15.2K Buy
558
+10
+2% +$249 ﹤0.01% 1804
2025
Q3 		$10.3K Sell
548
-10
-2% -$155 ﹤0.01% 1927
2025
Q2 		$6.13K Sell
558
-57
-9% -$526 ﹤0.01% 2085
2025
Q1 		$3.76K Buy
+615
New +$5.87K ﹤0.01% 2127

Other funds holding UPB

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Versant Capital Management's UPB Position: Q2 2026 in Review

Versant Capital Management sold out of Upstream Bio Inc (UPB) in Q2 2026, closing a stake of 762 shares — an estimated $6.86K sold.

Versant Capital Management first reported a position in UPB in Q1 2025 and held it in 5 quarters. The position peaked at $15.2K in Q4 2025. 5 funds tracked by Wall St. Rank hold UPB as of Q2 2026.

  • Versant Capital Management reported no remaining Upstream Bio Inc position as of Q2 2026 after selling out during the quarter.
  • Versant Capital Management sold 762 Upstream Bio Inc shares in Q2 2026, an estimated $6.86K.
  • Versant Capital Management first reported a position in Upstream Bio Inc in Q1 2025 and held it in 5 quarters.
  • Versant Capital Management's Upstream Bio Inc position peaked at $15.2K in Q4 2025.
  • 5 funds tracked by Wall St. Rank held Upstream Bio Inc as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.